Joshua Melson, MD

Dr. Melson is the Director of High-Risk Clinic for Gastrointestinal Cancers at our Cancer Center. His focus is on managing patients at elevated risk for gastrointestinal cancers and utilizing clinical expertise for cancer prevention. He specializes in colorectal cancer screening, surveillance, and endoscopic removal of precancerous lesions during colonoscopy. With grant funding from prominent foundations and the American Cancer Society, his research enhances colorectal cancer prevention through optimized colonoscopy. Dr. Melson also serves on the editorial review board of Gastrointestinal Endoscopy and takes an active role in advancing gastrointestinal care.

Cancer Focus

Dr. Melson's primary focus is managing high-risk individuals for gastrointestinal cancers, with emphasis on colorectal cancer. He excels in colorectal cancer screening, surveillance, and endoscopic removal of precancerous lesions.

Research Program Role

Cancer Prevention and Control Program

Display Name
Joshua Melson, MD

Publications

Van J, Alsayid M, Ma K, Vemulapalli K, Rex D, Melson J. 2023. Impact of Cold Snare vs Cold Forceps Resection of Diminutive Adenomas on Segmental Incomplete Resection Rate. Am J Gastroenterol. 118:1410–1418. doi:10.14309/ajg.0000000000002289.

Bresalier RS, Senore C, Young GP, Allison J, Benamouzig R, Benton S, Bossuyt PMM, Caro L, Carvalho B, Chiu H-M, et al. 2023 Jul. An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles. Gut. doi:10.1136/gutjnl-2023-329701.

Xicola RM, Gagnon M, Clark JR, Carroll T, Gao W, Fernandez C, Mijic D, Rawson JB, Janoski A, Pusatcioglu CK, et al. 2014. Excess of proximal microsatellite-stable colorectal cancer in African Americans from a multiethnic study. Clin Cancer Res. 20:4962–70. doi:10.1158/1078-0432.CCR-14-0353.

Joshua Melson, MD

Cancer Focus

Display NameJoshua Melson, MD

Publications

Display Name
Joshua Melson, MD